Table 2:

Patient treatment variables and outcomes

Patient	Target Vessel	Time to Treatment (min)	Additional Intervention	Posttreatment TIMI	Hemorrhage	Day 90 mRS
1	Basilar artery	2385	None	II	None	5
2	Left carotid T	85	None	III	None	3
3	Right carotid L	550	None	0	Asymptomatic SAH	4
4	Left middle cerebral artery	285	IA tPA	I	Asymptomatic ICH	2
5	Left carotid L	255	None	I	None	4
6	Left carotid L	1365	None	III	None	6
7	Right middle cerebral artery	320	IA Abciximab	II	None	0
8	Left carotid L	310	None	0	None	5
9	Left middle cerebral artery	320	None	II	None	1
10	Left middle cerebral artery	225	None	0	None	3
11	Right middle cerebral artery	190	IA tPA	II	Asymptomatic ICH	2
12	Left middle cerebral artery	480	None	III	Asymptomatic ICH	6
13	Right middle cerebral artery	330	None	II	None	0
14	Left middle cerebral artery	220	(IV tPA)	I	Asymptomatic ICH	3
15	Left middle cerebral artery	415	None	II	Asymptomatic SAH	6
16	Left carotid L	320	(IV tPA)	III	Symptomatic ICH	6
17	Right middle cerebral artery	355	(IV tPA)	III	Asymptomatic ICH	0
18	Right middle cerebral artery	390	None	II	None	4
19	Right carotid T	330	None	II	Asymptomatic ICH	4
20	Left middle cerebral artery	290	(IV tPA)	I	None	4
21	Left carotid L	135	None	0	None	6
22	Right middle cerebral artery	120	(IV tPA)	II	Symptomatic ICH	3
23	Left carotid T	160	None	II	Asymptomatic SAH	6
24	Left middle cerebral artery	295	None	0	None	6

Note:—TIMI indicates Thrombolysis in Myocardial Infarction; mRS, modified Rankin scale; carotid T, distal carotid artery, ipsilateral anterior cerebral artery, and ipsilateral middle cerebral artery; carotid L, distal carotid artery and ipsilateral middle cerebral artery; IA, intra-arterial; tPA, tissue plasminogen activator; SAH, subarachnoid hemorrhage; ICM, intracerebral hemorrhage.